ID

42528

Beschreibung

Dextromethorphan and Silymarin in Chronic Kidney Disease (CKD) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01091324

Link

https://clinicaltrials.gov/show/NCT01091324

Stichworte

  1. 2021-08-18 2021-08-18 -
Rechteinhaber

National Cheng-Kung University Hospital

Hochgeladen am

18 augusti 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Proteinuria NCT01091324

Eligibility Proteinuria NCT01091324

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min and and 0.5 g/day<proteinuria<3g/day.
Beschreibung

Chronic kidney disease stage | MDRD estimate | Proteinuria

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2074731
UMLS CUI [1,2]
C3839656
UMLS CUI [1,3]
C0033687
2. age between 18 and 75 years old.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
3. patients without hospitalization for cardiac or infection related morbidity over the previous 2 months(due to the potential confounding effects on baseline study variables).
Beschreibung

Recent hospitalization for cardiac morbidity absent | Recent hospitalization for infection related morbidity absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0018799
UMLS CUI [1,4]
C0332185
UMLS CUI [1,5]
C0332197
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0009450
UMLS CUI [2,4]
C0332185
UMLS CUI [2,5]
C0332197
4. patients who are able to provide consent to participate in the study.-
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients will significant mental illness, pregnant women, and other vulnerable populations.
Beschreibung

Significant mental illness | Pregnancy | Other vulnerable populations

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0750502
UMLS CUI [2]
C0032961
UMLS CUI [3,1]
C0949366
UMLS CUI [3,2]
C0205394
2. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
Beschreibung

Active hepatic disease | ALT mesurement increased

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205177
UMLS CUI [2,1]
C0201836
UMLS CUI [2,2]
C0442805
3. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
Beschreibung

History of congestive heart failure | NYHA classification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0018802
UMLS CUI [1,3]
C1275491
UMLS CUI [1,4]
C1457887
4. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
Beschreibung

Patients for whom living donor renal transplantation is already scheduled or in the process of being evaluate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C0348050
UMLS CUI [1,3]
C0205539
UMLS CUI [2,1]
C0022671
UMLS CUI [2,2]
C0348050
UMLS CUI [2,3]
C0220825
5. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
Beschreibung

Severe comorbidities

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
6. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
Beschreibung

Receiving immune modulating medications due to active inflammation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0678889
UMLS CUI [1,3]
C0021368
UMLS CUI [1,4]
C0205177
UMLS CUI [1,5]
C0678226
7. patients who are on corticosteroid therapy.
Beschreibung

Adrenal Cortex Hormones

Datentyp

boolean

Alias
UMLS CUI [1]
C0001617
8. patients who do not consent to participate in the study.
Beschreibung

Informed consent absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0332197

Ähnliche Modelle

Eligibility Proteinuria NCT01091324

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Chronic kidney disease stage | MDRD estimate | Proteinuria
Item
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min and and 0.5 g/day<proteinuria<3g/day.
boolean
C2074731 (UMLS CUI [1,1])
C3839656 (UMLS CUI [1,2])
C0033687 (UMLS CUI [1,3])
Age
Item
2. age between 18 and 75 years old.
boolean
C0001779 (UMLS CUI [1])
Recent hospitalization for cardiac morbidity absent | Recent hospitalization for infection related morbidity absent
Item
3. patients without hospitalization for cardiac or infection related morbidity over the previous 2 months(due to the potential confounding effects on baseline study variables).
boolean
C0019993 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
C0332197 (UMLS CUI [1,5])
C0019993 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,3])
C0332185 (UMLS CUI [2,4])
C0332197 (UMLS CUI [2,5])
Informed consent
Item
4. patients who are able to provide consent to participate in the study.-
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Significant mental illness | Pregnancy | Other vulnerable populations
Item
1. patients will significant mental illness, pregnant women, and other vulnerable populations.
boolean
C0004936 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2])
C0949366 (UMLS CUI [3,1])
C0205394 (UMLS CUI [3,2])
Active hepatic disease | ALT mesurement increased
Item
2. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
boolean
C0023895 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C0201836 (UMLS CUI [2,1])
C0442805 (UMLS CUI [2,2])
History of congestive heart failure | NYHA classification
Item
3. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
boolean
C0262926 (UMLS CUI [1,1])
C0018802 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
C1457887 (UMLS CUI [1,4])
Patients for whom living donor renal transplantation is already scheduled or in the process of being evaluate
Item
4. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
boolean
C0022671 (UMLS CUI [1,1])
C0348050 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0022671 (UMLS CUI [2,1])
C0348050 (UMLS CUI [2,2])
C0220825 (UMLS CUI [2,3])
Severe comorbidities
Item
5. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Receiving immune modulating medications due to active inflammation
Item
6. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
boolean
C0013227 (UMLS CUI [1,1])
C0678889 (UMLS CUI [1,2])
C0021368 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,4])
C0678226 (UMLS CUI [1,5])
Adrenal Cortex Hormones
Item
7. patients who are on corticosteroid therapy.
boolean
C0001617 (UMLS CUI [1])
Informed consent absent
Item
8. patients who do not consent to participate in the study.
boolean
C0021430 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video